- Home
- NVNI vs RADX Comparison
NVNI vs RADX Comparison
Compare NVNI & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNI
- RADX
- Stock Information
- Founded
- NVNI 2019
- RADX 2021
- Country
- NVNI Brazil
- RADX Australia
- Employees
- NVNI N/A
- RADX N/A
- Industry
- NVNI
- RADX
- Sector
- NVNI
- RADX
- Exchange
- NVNI Nasdaq
- RADX NYSE
- Market Cap
- NVNI 31.5M
- RADX 32.5M
- IPO Year
- NVNI N/A
- RADX N/A
- Fundamental
- Price
- NVNI $0.49
- RADX $4.64
- Analyst Decision
- NVNI
- RADX Strong Buy
- Analyst Count
- NVNI 0
- RADX 3
- Target Price
- NVNI N/A
- RADX $15.00
- AVG Volume (30 Days)
- NVNI 12.4M
- RADX 17.9K
- Earning Date
- NVNI 08-12-2025
- RADX 02-26-2025
- Dividend Yield
- NVNI N/A
- RADX N/A
- EPS Growth
- NVNI N/A
- RADX N/A
- EPS
- NVNI N/A
- RADX N/A
- Revenue
- NVNI $31,250,627.00
- RADX $204,609.00
- Revenue This Year
- NVNI $12.05
- RADX N/A
- Revenue Next Year
- NVNI $15.02
- RADX N/A
- P/E Ratio
- NVNI N/A
- RADX N/A
- Revenue Growth
- NVNI 1491.58
- RADX N/A
- 52 Week Low
- NVNI $0.14
- RADX $3.50
- 52 Week High
- NVNI $12.19
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- NVNI 57.10
- RADX N/A
- Support Level
- NVNI $0.35
- RADX N/A
- Resistance Level
- NVNI $0.83
- RADX N/A
- Average True Range (ATR)
- NVNI 0.08
- RADX 0.00
- MACD
- NVNI 0.03
- RADX 0.00
- Stochastic Oscillator
- NVNI 34.62
- RADX 0.00
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.